Ken serves biopharmaceutical clients on brand and corporate strategy engagements encompassing new product development, product launch planning, product positioning, pricing and contracting, licensing & development, due diligence, forecasting and market assessments in the US, Europe, and Emerging Markets. Ken joined Putnam from McKinsey & Co., where he advised major and specialty pharmaceutical manufacturers, drug distributors, and private equity firms. Prior to McKinsey, Ken was on the faculty of MIT, where he led a research group in computational chemistry, biomaterials, and drug delivery. Prior to MIT he worked at DuPont and the Swiss Federal Institute of Technology. Ken has a PhD from the University of Wisconsin and a B.S. from Purdue University, both in chemical engineering.